Jana Pöttgen

Jana Pöttgen

Auto-generated profile, based on publicly available information

Jana Pöttgen

Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JPJana Pöttgen
Jana Pöttgen
ARAnita Rose
Anita Rose
WVWim Van De Vis
Wim Van De Vis
JEJannie Engelbrecht
Jannie Engelbrecht
MPMichelle Pirard
Michelle Pirard
SKSascha Köpke
Sascha Köpke
Sexual dysfunction in multiple sclerosis (MS) is a significant, but often underestimated and overlooked suffering. Interventions to treat sexual dysfunction in MS are rare. The relation between sexual dysfunction in MS and psychological as well as neuropsychological aspects is evident. However, this field of research remains markedly underdeveloped in this severe chronic illness. The aim of this scoping review is to describe the relevant knowledge in this area and to identify psychological interventions to treat sexual dysfunctions in MS. A scoping review was conducted to answer the following questions: (1) Which psychological and neuropsychological factors impact on sexual dysfunction in MS and vice versa? (2) What kind of psychological interventions aiming to improve sexual dysfunctions in MS are available? A comprehensive search and review of MEDLINE, PsycINFO, and CINAHL was completed by using a recent methodological framework for scoping reviews. 23 publications covering a total of 13,259 people with MS and 532 healthy controls were identified. Sexual dysfunction was found to be very common in MS and there is an obvious relation to psychological disorders as e.g. depression and anxiety and also to psychological aspects as partner relationship and quality of life. The relation between sexual dysfunction in MS and neuropsychological impairment has only rarely been studied and no clear results were found. Only two studies were identified, assessing the effectiveness of psychological intervention studies on sexual dysfunction in people with MS, and a third study presenting a secondary analysis of a study targeting depression. All three studies reported significant improvements in sexual dysfunction as well as partly in psychological variables. There is a pressing need for the development and adequate evaluation of psychological interventions for sexual dysfunctions in MS. In addition, sexual dysfunction and its impact on psychological wellbeing should be more focussed in clinical care. This review is registered with PROSPERO; Registration number: CRD42016033066.

20 December 2016 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
JSJan‐Patrick Stellmann
Jan‐Patrick Stellmann
HCHanife Cetin
Hanife Cetin
KYKim Lea Young
Kim Lea Young
SHSibylle Hodecker
Sibylle Hodecker
JPJana Pöttgen
Jana Pöttgen
SSSusanne Siemonsen
Susanne Siemonsen
Background: Neurodegeneration in multiple sclerosis (MS) may be investigated in the visual system as optical coherence tomography (OCT) and magnetic resonance imaging (MRI) allows examining structural integrity in detail. The association between thickness of retinal layers and focal cortical volumes beyond the primary visual system has not been thoroughly investigated.Objective: To investigate the association between focal cortical volume and thickness of retinal layers.Methods: Fifty‐four patients (relapsing–remitting MS, mean age 40.5 years, mean disease duration 7.6 years, median EDSS 2) underwent OCT and MRI. The association between focal cortical volume and OCT measurements was investigated with voxel‐based morphometry (VBM). Patterns of association were determined with Yeo's functional network atlas and the Harvard‐Oxford cortical atlas. We used GEE models with cortical volumes from the FreeSurfer parcellation to confirm VBM results. Post hoc, we analyzed the association between OCT, focal cortical volumes, and an extended neuropsychological assessment in a subgroup of 14 patients.Results: Macular retinal nerve fiber layer (mRNFL) and ganglion cell /inner plexiform layer (GCIPL) showed a robust association with mainly the insular cortex and the cingulate cortex. VBM findings were confirmed with FreeSurfer volumes. The post hoc analysis detected significant correlations between both OCT outcomes and cognition.Conclusion: Besides the primary visual system, OCT outcomes show a correlation pattern with cortical regions that are known to be important for cognitive performance, predominantly the insula in both hemispheres. Thus, OCT should be further investigated as a marker for neurodegeneration in MS.

AGAmbra Mara Giovannetti
Ambra Mara Giovannetti
JPJana Pöttgen
Jana Pöttgen
EAElisenda Anglada
Elisenda Anglada
RMRebeca Menéndez
Rebeca Menéndez
JHJürgen Hoyer
Jürgen Hoyer
Alessandra SolariAlessandra Solari
Alessandra Solari
Purpose: The Comprehensive assessment of Acceptance and Commitment Therapy (ACT) processes (CompACT) is a 23-item self-report questionnaire assessing psychological flexibility, which is the overarching construct underpinning the ACT framework. We conducted a two-phase project to develop validated versions of the CompACT in three languages: phase 1—cross-cultural adaptation; and phase 2—psychometric validation of the questionnaire for use in Italy, Germany and Spain. This article focuses on the first phase. Methods: We translated and culturally adapted the CompACT in the three target languages, following the ISPOR TCA Task Force guidelines. The process was overseen by a translation panel (three translators, at least two multiple sclerosis (MS) researchers and a lay person), ACT experts and clinicians from the research team of each country and the original CompACT developers. We debriefed the new questionnaire versions via face-to-face interviews with a minimum of four adults from the general population (GP) and four adults with MS in each country. Results: The translation-adaptation process went smoothly in the three countries, with some items (7 in Italy, 4 in Germany, 6 in Spain) revised after feedback from ACT experts. Cognitive debriefing showed that the CompACT was deemed easy to understand and score in each target country by both GP and MS adults. Conclusions: The Italian, German and Spanish versions of the CompACT have semantic, conceptual and normative equivalence to the original scale and good content validity. Our findings are informative for researchers adapting the CompACT and other self-reported outcome measures into multiple languages and cultures.

19 April 2019 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
GPGesa E. A. Pust
Gesa E. A. Pust
JPJana Pöttgen
Jana Pöttgen
JRJennifer Randerath
Jennifer Randerath
SLStephanie Lau
Stephanie Lau
Christoph HeesenChristoph Heesen
Christoph Heesen
IPIris-Katharina Penner
Iris-Katharina Penner

1 November 2017 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
Christoph HeesenChristoph Heesen
Christoph Heesen
JPJ. Pöttgen
J. Pöttgen
ARA.C. Rahn
A.C. Rahn
KLK. Liethmann
K. Liethmann
JKJ. Kasper
J. Kasper
Alessandra SolariAlessandra Solari
Alessandra Solari

16 February 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
NKNicole Krause
Nicole Krause
KRKarin Riemann-Lorenz
Karin Riemann-Lorenz
TSTanja Steffen
Tanja Steffen
ARAnne Christin Rahn
Anne Christin Rahn
JPJana Pöttgen
Jana Pöttgen
Christoph HeesenChristoph Heesen
Christoph Heesen
Introduction Multiple sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system that mainly affects young adults. Uncertainty is a major psychological burden of the disease from diagnosis to prognosis, enhanced by the pressure to make early decisions on a diverse set of immunotherapies. Watchful waiting for 1–2 years while adapting goals and lifestyle habits to life with a chronic disease represents another reasonable option for persons with MS (PwMS). A behaviour change programme based on evidence-based patient information (EBPI) is not available in standard care. This randomised controlled trial (RCT) with an embedded process evaluation investigates the efficacy and cost-effectiveness of a web-based behavioural lifestyle programme to change lifestyle behaviour and reduce inflammatory disease activity in PwMS. Methods and analysis A web-based behavioural intervention will be evaluated in an RCT aiming to recruit 328 persons with clinically isolated syndrome, suspected MS or confirmed MS for less than 1 year, who have not yet started immunotherapy. Moreover, a mixed-methods process evaluation and a health economic evaluation will be carried out. Participants will be recruited in at least 16 MS centres across Germany and randomised to an intervention group with 12 months of access to EBPI about lifestyle factors in MS, combined with a complex behaviour change programme or to a control group (optimised standard care). The combined primary endpoint is the incidence of new T2 lesions on MRI or confirmed relapses. Ethics and dissemination The study has been approved by the Ethics Committee of the Hamburg Chamber of Physicians (PV6015). Trial results will be communicated at scientific conferences and meetings and presented on relevant patient websites and in patient education seminars. Trial registration number ClinicalTrials.gov Registry (NCT03968172); Pre-results.